Risperidone 3 mg

DRUG2 trials

Sponsors

Janssen Research & Development, LLC, Janssen-Cilag International NV

Conditions

Schizophrenia

Phase 4

A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities

CompletedNCT03713658

Janssen Research & Development, LLCSchizophrenia

Start: 2018-10-18End: 2019-12-02Updated: 2025-04-27

A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

CompletedNCT04940039

Janssen-Cilag International NVSchizophrenia

Start: 2021-07-22End: 2024-04-16Updated: 2025-04-27

Related Papers

Feasibility study to evaluate capabilities for conducting psychiatric clinical research within the Rwandan mental healthcare system

BMJ Open2023-04-01